Is this your firm? Get featured or correct your listing →
Strategy
Stages
Early clinical-stage (Phase 1/2)
Sectors
Biotech
Check size
$15M-$30MRecent changes
- Sep 6, 2026Sep 6, 2026Sectors updated: Biotech ascentacap.com
- Sep 6, 2026Sep 6, 2026Check size updated: $15M-$30M ascentacap.com
- Sep 6, 2026Sep 6, 2026Stages updated: Early clinical-stage (Phase 1/2) ascentacap.com
Portfolio
5 totalCo-Investors
12OrbiMed Advisors · 4 sharedQatar Investment Authority · 2 shared5AM Ventures · 1 sharedAbingworth · 1 sharedARK Invest · 1 sharedAtlas Venture · 1 sharedBain Capital Life Sciences · 1 sharedBlackRock · 1 sharedCormorant Asset Management · 1 sharedSR One Capital Management · 1 sharedViking Global Investors · 1 sharedWestlake Village BioPartners · 1 shared
Similar Firms
overlapping sector, stage or regionLatest Pulse
- Sep 25, 2026ADARx Prices $446M IPO, Debuts As ADRXADARx Pharmaceuticals priced an upsized $446 million IPO at $17 a share and began trading on the Nasdaq as ADRX, joining the fall biotech IPO window alongside its existing AbbVie drug partnership.→
- Jun 18, 2026Triveni Bio Raises $65M for Antibody Therapeutics in ImmunologyTriveni Bio raised $65 million, co-led by Ascenta Capital and Janus Henderson Investors, to advance antibody-based therapeutics for immunological and inflammatory diseases. The round is a reminder that biotech capital is still flowing to differentiated science even in an AI-dominated market.→
- Jun 17, 2026Triveni Bio Raises $65M for Antibody-Based Immunology TherapeuticsTriveni Bio raised $65 million co-led by Ascenta Capital and Janus Henderson to advance antibody-based therapeutics targeting immunological diseases. The round is part of a biotech rebound that's running alongside the AI-infrastructure boom rather than being crowded out by it.→
Ascenta Capital FAQ
What companies has Ascenta Capital invested in?
Ascenta Capital's portfolio includes Iambic Therapeutics, ADARx, Latigo Biotherapeutics, Triveni Bio, Iambic.
Who does Ascenta Capital co-invest with most?
In the rounds Value Add tracks, Ascenta Capital most often invests alongside OrbiMed Advisors (4 shared deals), Qatar Investment Authority (2 shared deals), 5AM Ventures (1 shared deal), Abingworth (1 shared deal), ARK Invest (1 shared deal).